awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38062881-1A85356D-0E18-49CE-9853-C6283A33A999
Q38062881-1A85356D-0E18-49CE-9853-C6283A33A999
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38062881-1A85356D-0E18-49CE-9853-C6283A33A999
Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.
P2860
Q38062881-1A85356D-0E18-49CE-9853-C6283A33A999
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38062881-1A85356D-0E18-49CE-9853-C6283A33A999
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f486f951d669335f779e1b8ad7534810419882fd
P2860
Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial.